Exploring the Potential of CAR T-Cell Therapy in Head and Neck Cancer

Sophie Papa, PhD, MBBS, MRCP, King’s College London in the United Kingdom, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with head and neck cancer.